ECAT to hold a series of online meetings with pharmaceutical companies
As part of its annual activities, the Eurasian Community for Access to Treatment (ECAT) will organize several online meetings with pharmaceutical companies to discuss issues related to the registration, pricing, and availability of essential medicines in Eastern Europe and Central Asia (EECA).
Invitation to Webinar: Community Participation in the Development of National Strategic Plans on TB
TB Europe Coalition invites everyone to join the educational webinar “Strengthening Community Knowledge and Engagement in the Development of National Strategic Plans (NSPs)”, which will take place on 17 September 2025, from 11:00 to 12:30 CET. You can register via this link.
The U.S., Gilead, and the Global Fund Launch Major Initiative to Expand Access to Lenacapavir
The U.S. Department of State, Gilead Sciences, and the Global Fund to Fight AIDS, Tuberculosis and Malaria have announced the launch of a large-scale initiative to expand access to lenacapavir — the first injectable HIV prevention medication administered just twice a year.
CSEM Opens Call for Applications to Join the Advisory Group
The Civil Society Engagement Mechanism for UHC2030 (CSEM) is now accepting nominations for nine open positions on its Advisory Group.
Summary Report on Community-Led Assessment of Access to Viral Load and Drug Resistance Testing in the Kyrgyz Republic and the Republic of Belarus
In 2023–2024, our partners in Kyrgyzstan and Belarus conducted an assessment of access to viral load and drug resistance testing. Our team has prepared a summary report based on data collected over the past year, providing an analysis of the current situation in both countries.
Global Fund Board Community Delegation announces new members
Three representatives from the EECA region were elected to the Community Delegation of the Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria: Denis Godlevskiy, Regional Coordinator of ITPC EECA, Valeriia Rachynska, Director of the Communities Development Department of theCharitable Organization “100%LIFE” and Lyubov Vorontsova, representative of the Eurasian Women’s Network on AIDS and member of the Steering
Russian patient organizations ask Gilead to disclaim patents for Truvada
September 3, twenty-five patient organizations working in the field of HIV response in Russia published an open letter to Gilead Sciences, asking the pharmaceutical company to disclaim patent rights for the combination of tenofovir and emtricitabine, marketed under the tradename Truvada.
The Analysis of Procurement of ARV Drugs in the Russian Federation in 2018
ITPCru team is glad to present their report on ARVs procurement monitoring in Russia in 2018.
On the way to 90: Analysis of procurement and provision of ARV drugs in seven countries of Eastern Europe and Central Asia
ITPCru is proud to present its first regional report on procurement and provision of antiretroviral drugs in 7 countries of Eastern Europe and Central Asia in 2017. The report is based on a series of national reports implemented by patient organizations in the respective countries (Armenia, Belarus, Kazakhstan, Kyrgyzstan, Moldova, Russia, Ukraine).
ITPCru’s statement on ARV stock-outs in Kazakhstan
Treatment Preparedness Coalition in Eastern Europe and Central Asia (ITPCru) expresses its deep concern over the situation in Kazakhstan where hundreds of people for several weeks have been facing stock-outs of life-saving antiretroviral treatment.